activins and Breast Cancer

activins has been researched along with Breast Cancer in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (12.20)18.2507
2000's15 (36.59)29.6817
2010's19 (46.34)24.3611
2020's2 (4.88)2.80

Authors

AuthorsStudies
Andersen, C; Cheng, Q; Jabbari, K; Khoshdeli, M; Parvin, B; Winkelmaier, G; Yaswen, P1
Alard, A; Daviaud, C; De Martino, M; Demaria, S; Diamond, JM; Formenti, SC; Kraynak, J; Miller, LD; Vanpouille-Box, C1
Cui, X; Deng, J; Feng, W; Lin, F; Liu, Z; Santos, S; Tian, G; Wu, J; Xie, D; Yang, K1
Bao, YL; Fan, C; Huang, YX; Li, YX; Liu, T; Ni, JS; Song, ZB; Sun, LG; Wu, P; Wu, Y; Yu, CL1
Brown, J; Coleman, R; D'Oronzo, S; Handforth, C1
Harada, M; Kobayashi, M; Koinuma, D; Miyazono, K; Morikawa, M; Ozawa, T; Seto, Y; Tada, K; Takahashi, K; Tamura, Y; Tanabe, M1
Mantzoros, CS; Panagiotou, G; Papakonstantinou, E; Polyzos, SA; Vagionas, A1
Keri, RA; Seachrist, DD1
Hanahan, D; Marinoni, I; Michael, IP; Perren, A; Saghafinia, S; Tichet, M; Zangger, N1
Lebrun, JJ; Neel, JC1
de Kretser, DM; Forrester, HB; Ivashkevich, A; Leong, T; McKay, MJ; Sprung, CN1
Choe, S; Jung, JW; Kwiatkowski, W; Lee, DK; Shim, SY1
Coleman, RE; Holen, I; Ottewell, P; Wilson, C1
Aykul, S; Martinez-Hackert, E1
Buzelin, MA; Couto, HL; Dela Cruz, C; Reis, FM; Toppa, NH; Wainstein, AJ1
Ancona, C; Badalamenti, G; Crescimanno, M; Flandina, C; Fulfaro, F; Incorvaia, L; Leto, G; Sepporta, MV1
Choy, L; Derynck, R; Knouse, KA; Liu, IM; Schilling, SH; Wang, XF1
Bao, YL; Guan, LL; Li, YX; Li, ZD; Meng, XY; Wang, YZ; Wu, Y; Yu, CL1
Ali, MA; Fleming, JM; Ginsburg, E; Meyer, MJ; Pesesky, MW; Vonderhaar, BK1
Berman, H; Fessenden, T; Fordyce, C; Jung, J; Pickering, C; Singla, V; Tlsty, T1
Banz-Jansen, C; Diedrich, K; Finas, D; Münchow, B1
Dunphy, KA; Hagen, MJ; Jerry, DJ; Schneyer, AL1
Peng, C; Wang, X; Xu, G; Yang, C; Zeng, F; Zhou, H; Zhou, T1
Kang, J; Liu, N; Song, C; Yan, H; Zhu, S1
Jeruss, JS; Rademaker, AW; Sturgis, CD; Woodruff, TK1
Adkins, HB; Benjamin, C; Bianco, C; Chen, LL; Cheung, AE; De Luca, A; Jarpe, M; LePage, D; Miatkowski, K; Normanno, N; Olson, D; Orozco, O; Rayhorn, P; Salomon, D; Sanicola, M; Schiffer, SG; Williams, KP; Zafari, M1
Brachtel, E; Carey, JL; Donahoe, PK; Gupta, V; Hoshiya, Y; Kawakubo, H; Maheswaran, S; Sasur, L; Scott, A1
Gupta, V; Harkin, DP; Kawakubo, H; Maheswaran, S1
Camargos, AF; Carneiro, MM; Cobellis, L; Federico, M; Luisi, S; Petraglia, F; Reis, FM1
Burdette, JE; Jeruss, JS; Kurley, SJ; Lee, EJ; Woodruff, TK1
Alves, F; Augustin, HG; Dullin, C; Kimmina, S; Krneta, J; Kroll, J; Phillips, DJ; Prahst, C; Sananbenesi, F1
Badalamenti, G; Crescimanno, M; Flandina, C; Gebbia, N; Incorvaia, L; Leto, G; Rini, G; Tumminello, FM1
Ay, AS; Bartholin, L; Goddard-Léon, S; Joguet, S; Razanajaona, D; Rimokh, R; Treilleux, I1
Burdette, JE; Woodruff, TK1
de Winter, JP; Kalkhoven, E; Mummery, CL; Roelen, BA; van den Eijnden-van Raaij, AJ; van der Burg, B; van der Saag, PT1
Buluwela, L; Coombes, RC; Davies, D; Gomes, P; Gomm, JJ; Liu, QY; Niranjan, B1
Ying, SY; Zhang, Z1
de Winter, JP; Roelen, BA; ten Dijke, P; van den Eijnden-van Raaij, AJ; van der Burg, B1
Beltrami, CA; Cataldi, P; Di Loreto, C; Luisi, S; Petraglia, F; Reis, FM; Zuiani, C1
Ali, S; Cocolakis, E; Lebrun, JJ; Lemay, S1
Anania, G; Cobellis, L; Di Blasio, AM; Gioffrè, W; Luisi, S; Petraglia, F; Reis, FM; Silva, IS; Tameirão, LC1

Reviews

5 review(s) available for activins and Breast Cancer

ArticleYear
Cancer Treatment and Bone Health.
    Calcified tissue international, 2018, Volume: 102, Issue:2

    Topics: Activins; Androgens; Antineoplastic Agents; Bone and Bones; Breast Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Inhibins; Male; Osteoporosis; Practice Guidelines as Topic; Prostatic Neoplasms

2018
The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.
    Endocrinology, 2019, 05-01, Volume: 160, Issue:5

    Topics: Activins; Animals; Breast Neoplasms; Female; Follistatin; Gene Expression Regulation, Neoplastic; Humans; Inhibins; Mammary Glands, Human; Signal Transduction

2019
The role of activin in mammary gland development and oncogenesis.
    Journal of mammary gland biology and neoplasia, 2011, Volume: 16, Issue:2

    Topics: Activins; Animals; Breast Neoplasms; Female; Humans; Mammary Glands, Animal; Mammary Glands, Human; Mammary Neoplasms, Experimental; Signal Transduction; Transforming Growth Factor beta

2011
Transforming Growth Factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents.
    Current cancer drug targets, 2004, Volume: 4, Issue:2

    Topics: Activins; Animals; Anti-Mullerian Hormone; Antineoplastic Agents; Biomarkers, Tumor; Bone Morphogenetic Proteins; Breast Neoplasms; Female; Glycoproteins; Humans; Inhibins; Nodal Protein; Signal Transduction; Testicular Hormones; Transforming Growth Factor beta

2004
Activin, inhibin and the human breast.
    Molecular and cellular endocrinology, 2004, Oct-15, Volume: 225, Issue:1-2

    Topics: Activins; Breast; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibin-beta Subunits; Inhibins; Protein Subunits

2004

Other Studies

36 other study(ies) available for activins and Breast Cancer

ArticleYear
Overexpression of CD36 in mammary fibroblasts suppresses colony growth in breast cancer cell lines.
    Biochemical and biophysical research communications, 2020, 05-21, Volume: 526, Issue:1

    Topics: Activins; Breast Neoplasms; CD36 Antigens; Cell Line, Tumor; Cell Polarity; Cell Proliferation; Cells, Cultured; Down-Regulation; Female; Fibroblasts; Humans; Mammary Glands, Human; Phosphorylation; Smad Proteins; Tumor Stem Cell Assay; YY1 Transcription Factor

2020
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
    Cancer immunology research, 2021, Volume: 9, Issue:1

    Topics: Activins; Animals; Breast Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Humans; Immunosuppression Therapy; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor Microenvironment

2021
The effects of activin A on the migration of human breast cancer cells and neutrophils and their migratory interaction.
    Experimental cell research, 2017, 08-01, Volume: 357, Issue:1

    Topics: Activins; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Humans; Inflammation; Neutrophils; Transforming Growth Factor beta

2017
Testes-specific protease 50 promotes cell proliferation via inhibiting activin signaling.
    Oncogene, 2017, 10-26, Volume: 36, Issue:43

    Topics: Activins; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Male; Mice; NF-kappa B; Proliferating Cell Nuclear Antigen; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Serine Endopeptidases; Signal Transduction; Smad2 Protein; Testis; Xenograft Model Antitumor Assays

2017
Palbociclib enhances activin-SMAD-induced cytostasis in estrogen receptor-positive breast cancer.
    Cancer science, 2019, Volume: 110, Issue:1

    Topics: Activins; Breast Neoplasms; Cell Cycle; Cell Line; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cytostatic Agents; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyridines; Receptors, Estrogen; Smad2 Protein

2019
Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.
    The Journal of clinical endocrinology and metabolism, 2019, 02-01, Volume: 104, Issue:2

    Topics: Activins; Adult; Age Factors; Aged; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Female; Follistatin; Follistatin-Related Proteins; Humans; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor I; Middle Aged; Pregnancy-Associated Plasma Protein-A

2019
ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.
    Developmental cell, 2019, 05-06, Volume: 49, Issue:3

    Topics: Activin Receptors, Type I; Activins; Animals; Apoptosis; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Heterografts; Homeostasis; Humans; Male; Mice; Mice, Inbred A; Mice, Inbred C57BL; Mice, SCID; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Tumor Microenvironment

2019
Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells.
    Cellular signalling, 2013, Volume: 25, Issue:7

    Topics: Activins; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Invasiveness; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta

2013
Follistatin is induced by ionizing radiation and potentially predictive of radiosensitivity in radiation-induced fibrosis patient derived fibroblasts.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Activins; Alternative Splicing; Breast Neoplasms; Exons; Female; Fibroblasts; Fibrosis; Follistatin; Gene Expression Regulation, Neoplastic; Humans; Primary Cell Culture; Protein Isoforms; Radiation Tolerance; Radiation, Ionizing; Signal Transduction

2013
An Activin A/BMP2 chimera, AB215, blocks estrogen signaling via induction of ID proteins in breast cancer cells.
    BMC cancer, 2014, Jul-29, Volume: 14

    Topics: Activins; Bone Morphogenetic Protein 2; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Female; Humans; Inhibitor of Differentiation Proteins; MCF-7 Cells; Neoplasm Transplantation; Recombinant Fusion Proteins; Signal Transduction; Tamoxifen; Xenograft Model Antitumor Assays

2014
The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway.
    BMC cancer, 2015, Feb-14, Volume: 15

    Topics: Activins; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Female; Follistatin; Humans; Imidazoles; MCF-7 Cells; Mice; Phosphorylation; Receptors, Estrogen; Signal Transduction; Smad2 Protein; Xenograft Model Antitumor Assays; Zoledronic Acid

2015
New Ligand Binding Function of Human Cerberus and Role of Proteolytic Processing in Regulating Ligand-Receptor Interactions and Antagonist Activity.
    Journal of molecular biology, 2016, Feb-13, Volume: 428, Issue:3

    Topics: Activins; Amino Acid Sequence; Animals; Bone Morphogenetic Proteins; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cytokines; Female; Humans; Molecular Sequence Data; Proteolysis; Sequence Alignment; Signal Transduction; Transforming Growth Factor beta

2016
Follistatin Expression in Human Invasive Breast Tumors: Pathologic and Clinical Associations.
    Applied immunohistochemistry & molecular morphology : AIMM, 2018, Volume: 26, Issue:2

    Topics: Activins; Breast Neoplasms; Carcinogenesis; Cell Cycle; Cell Proliferation; Disease Progression; Estrogen Receptor alpha; Female; Follistatin; Follow-Up Studies; Humans; Immunohistochemistry; Mammary Glands, Human; Menopause; Neoplasm Metastasis; Neoplasm Staging; Paraffin Embedding; Receptor, ErbB-2

2018
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report.
    Cancer investigation, 2016, Oct-20, Volume: 34, Issue:9

    Topics: Activins; Aged; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Cathepsin L; Cystatin C; Disease Progression; Female; Follistatin; Humans; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Osteoporosis; ROC Curve

2016
TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
    The EMBO journal, 2009, Jan-21, Volume: 28, Issue:2

    Topics: Activins; Animals; Benzamides; Bone Morphogenetic Proteins; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Dioxoles; Humans; Mice; Phosphorylation; Protein Binding; Protein Isoforms; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad1 Protein; Smad5 Protein; Transforming Growth Factor beta

2009
Identification and characterization of human ARIP2 and its relation to breast cancer.
    Cytokine, 2009, Volume: 46, Issue:2

    Topics: Activin Receptors, Type II; Activins; Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Base Sequence; Breast; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Female; Humans; Membrane Proteins; Mice; Molecular Sequence Data; Protein Isoforms; RNA, Small Interfering; Transcription, Genetic; Two-Hybrid System Techniques

2009
Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.
    Breast cancer research : BCR, 2009, Volume: 11, Issue:6

    Topics: Activins; Animals; Breast Neoplasms; CD24 Antigen; Cell Line, Tumor; Female; Humans; Hyaluronan Receptors; Mesoderm; Mice; Mice, Nude; Neoplasm Invasiveness; Nodal Protein; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous

2009
DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:2

    Topics: Activins; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p16; Cyclooxygenase 2; DNA Damage; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Gene Expression Profiling; Humans; Immunohistochemistry; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Precancerous Conditions; Protein Serine-Threonine Kinases; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Telomere; Telomeric Repeat Binding Protein 2; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2010
Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line.
    Archives of gynecology and obstetrics, 2011, Volume: 284, Issue:6

    Topics: Activins; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunohistochemistry; Proteasome Endopeptidase Complex; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Smad2 Protein; Smad3 Protein; Smad4 Protein

2011
Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:4

    Topics: Activin Receptors, Type I; Activins; Adult; Aged; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Lymphatic Metastasis; Middle Aged; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta

2012
Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cells.
    Cellular signalling, 2012, Volume: 24, Issue:4

    Topics: Activins; Benzamides; Bone Morphogenetic Proteins; Breast Neoplasms; Calcium-Binding Proteins; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytoskeletal Proteins; Dioxoles; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mad2 Proteins; Nocodazole; Nuclear Proteins; Plasmids; Poly-ADP-Ribose Binding Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Repressor Proteins; Signal Transduction; Transfection; Transforming Growth Factor beta

2012
Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer.
    Cancer research, 2003, Jul-01, Volume: 63, Issue:13

    Topics: Activin Receptors; Activins; Breast; Breast Neoplasms; DNA-Binding Proteins; Female; Humans; Immunohistochemistry; Reference Values; Signal Transduction; Smad Proteins; Trans-Activators

2003
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    The Journal of clinical investigation, 2003, Volume: 112, Issue:4

    Topics: Activin Receptors, Type I; Activins; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Division; Cell Separation; Cell Transformation, Neoplastic; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Epidermal Growth Factor; Epitopes; Flow Cytometry; GPI-Linked Proteins; Humans; Immunoblotting; Immunoglobulin G; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Ligands; Male; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Nodal Protein; Plasmids; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured

2003
Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells.
    The Journal of biological chemistry, 2003, Dec-19, Volume: 278, Issue:51

    Topics: Activins; Adult; Aged; Aged, 80 and over; Animals; Anti-Mullerian Hormone; Apoptosis; Biopsy; Breast Neoplasms; Cell Division; Cell Line, Tumor; DNA-Binding Proteins; Drug Synergism; Female; Gene Expression Regulation; Glycoproteins; Humans; Inhibin-beta Subunits; Interferon Regulatory Factor-1; Interferon-gamma; Mice; Mice, Inbred C3H; Middle Aged; Phosphoproteins; Rats; S Phase; Testicular Hormones

2003
Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells.
    Cancer research, 2005, Sep-01, Volume: 65, Issue:17

    Topics: Activins; Adenoviridae; beta-Galactosidase; Breast Neoplasms; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cyclin-Dependent Kinases; DNA-Binding Proteins; Humans; Inhibin-beta Subunits; Phosphorylation; Retinoblastoma Protein; Smad3 Protein; Trans-Activators; Transfection

2005
Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.
    Cancer research, 2006, Jun-01, Volume: 66, Issue:11

    Topics: Activins; Animals; Apoptosis; Breast Neoplasms; Carcinoma, Renal Cell; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Follistatin; Humans; Kidney Neoplasms; Mice; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Transfection; Transplantation, Heterologous

2006
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer.
    Clinical & experimental metastasis, 2006, Volume: 23, Issue:2

    Topics: Activins; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Middle Aged; Osteoporosis; Prostatic Hyperplasia; Prostatic Neoplasms; Sensitivity and Specificity

2006
Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth.
    Cancer research, 2007, Aug-01, Volume: 67, Issue:15

    Topics: Activins; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Follistatin; Follistatin-Related Proteins; Gene Silencing; Humans; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Smad2 Protein; Transfection; Transforming Growth Factor beta1; Tumor Cells, Cultured

2007
Activin and estrogen crosstalk regulates transcription in human breast cancer cells.
    Endocrine-related cancer, 2007, Volume: 14, Issue:3

    Topics: Activin Receptors, Type I; Activins; Breast Neoplasms; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Plasminogen Activator Inhibitor 1; Receptor Cross-Talk; Response Elements; Smad3 Protein; Transcription, Genetic; Transfection; Tumor Cells, Cultured

2007
Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1995, Volume: 6, Issue:9

    Topics: Activins; Base Sequence; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Growth Substances; Humans; Inhibins; Molecular Sequence Data; Receptors, Estrogen; Receptors, Transforming Growth Factor beta; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured

1995
Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells.
    Cancer research, 1996, Mar-01, Volume: 56, Issue:5

    Topics: Activins; Base Sequence; Breast; Breast Neoplasms; Cell Division; Female; Humans; Inhibins; Molecular Sequence Data; Morphogenesis; Organ Culture Techniques; Tumor Cells, Cultured

1996
Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.
    Breast cancer research and treatment, 1996, Volume: 37, Issue:2

    Topics: Activin Receptors; Activins; Adenocarcinoma; Base Sequence; Breast Neoplasms; Female; Humans; Immunohistochemistry; In Situ Hybridization; Inhibins; Molecular Sequence Data; Polymerase Chain Reaction; Receptors, Growth Factor; RNA, Messenger; Tumor Cells, Cultured

1996
DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells.
    Oncogene, 1997, Apr-24, Volume: 14, Issue:16

    Topics: Activins; Alternative Splicing; Amino Acid Sequence; Base Sequence; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Breast Neoplasms; Cell Division; DNA Primers; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Gene Deletion; Genes, Tumor Suppressor; Humans; Inhibins; Luciferases; Molecular Sequence Data; Pancreatic Neoplasms; Polymerase Chain Reaction; Recombinant Fusion Proteins; Repressor Proteins; Sequence Deletion; Sequence Homology, Amino Acid; Smad4 Protein; Trans-Activators; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured

1997
Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid.
    European journal of endocrinology, 1999, Volume: 141, Issue:2

    Topics: Activins; Body Fluids; Breast; Breast Neoplasms; Carcinoma; Cell Differentiation; Female; Fibrocystic Breast Disease; Growth Substances; Humans; Inhibins

1999
The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin.
    The Journal of biological chemistry, 2001, May-25, Volume: 276, Issue:21

    Topics: Activins; Breast Neoplasms; Cell Division; Female; Humans; Inhibins; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Transforming Growth Factor beta; Tumor Cells, Cultured

2001
Serum and tissue expression of activin a in postmenopausal women with breast cancer.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:5

    Topics: Activins; Aged; Biomarkers, Tumor; Breast Diseases; Breast Neoplasms; Female; Humans; Inhibin-beta Subunits; Middle Aged; Postmenopause; Postoperative Period; Prospective Studies; Reference Values; RNA, Messenger

2002